Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
TBI Quote, Financials, Valuation and Earnings
Last price:
$6.90
Seasonality move
:
-0.43%
Day range:
$6.20 - $6.55
52-week range:
$3.45 - $12.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
0.64x
Volume:
177.9K
Avg. volume:
204.1K
1-year change:
-41.46%
Market cap:
$193.5M
Revenue:
$1.6B
EPS (TTM):
-$4.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.2B | $2.3B | $1.9B | $1.6B | |
| Revenue Growth (YoY) | -22.05% | 17.73% | 3.71% | -15.44% | -17.78% | |
| Cost of Revenues | $1.4B | $1.6B | $1.7B | $1.4B | $1.2B | |
| Gross Profit | $440.6M | $560.3M | $602.1M | $506.1M | $406.4M | |
| Gross Profit Margin | 23.87% | 25.78% | 26.71% | 26.55% | 25.93% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $408.3M | $464.3M | $500.7M | $494.6M | $410.9M | |
| Other Inc / (Exp) | -$175.2M | -- | -- | -$9.5M | -$59.7M | |
| Operating Expenses | $440.3M | $491.9M | $530M | $520.4M | $439.5M | |
| Operating Income | $307K | $68.4M | $72.2M | -$14.4M | -$33.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$173.3M | $73.9M | $73.4M | -$20.6M | -$88.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$31.4M | $12.2M | $11.1M | -$6.5M | $37.2M | |
| Net Income to Company | -$141.8M | $61.6M | $62.3M | -$14.2M | -$125.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$141.8M | $61.6M | $62.3M | -$14.2M | -$125.7M | |
| Basic EPS (Cont. Ops) | -$4.01 | $1.77 | $1.89 | -$0.45 | -$4.17 | |
| Diluted EPS (Cont. Ops) | -$4.01 | $1.74 | $1.86 | -$0.45 | -$4.17 | |
| Weighted Average Basic Share | $35.4M | $34.8M | $32.9M | $31.3M | $30.2M | |
| Weighted Average Diluted Share | $35.4M | $35.4M | $33.4M | $31.3M | $30.2M | |
| EBITDA | $32.3M | $96M | $101.5M | $11.5M | -$3.5M | |
| EBIT | $307K | $68.4M | $72.2M | -$14.4M | -$33.1M | |
| Revenue (Reported) | $1.8B | $2.2B | $2.3B | $1.9B | $1.6B | |
| Operating Income (Reported) | $307K | $68.4M | $72.2M | -$14.4M | -$33.1M | |
| Operating Income (Adjusted) | $307K | $68.4M | $72.2M | -$14.4M | -$33.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $458.7M | $551.5M | $465.3M | $402.9M | $370.3M | |
| Revenue Growth (YoY) | -7.19% | 20.23% | -15.64% | -13.42% | -8.09% | |
| Cost of Revenues | $348.1M | $411.7M | $342.2M | $303.5M | $283.9M | |
| Gross Profit | $110.6M | $139.8M | $123.1M | $99.4M | $86.3M | |
| Gross Profit Margin | 24.11% | 25.36% | 26.46% | 24.67% | 23.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $97.4M | $120.6M | $122.6M | $106.9M | $94.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $104.4M | $127.9M | $129.1M | $114.9M | $100.5M | |
| Operating Income | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.8M | $12.5M | -$4.9M | -$13.9M | -$13.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$112K | $2M | -$640K | -$12.2M | $418K | |
| Net Income to Company | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Basic EPS (Cont. Ops) | $0.20 | $0.31 | -$0.13 | -$0.05 | -$0.48 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.30 | -$0.13 | -$0.05 | -$0.48 | |
| Weighted Average Basic Share | $34.7M | $33.9M | $32.3M | $31.1M | $29.7M | |
| Weighted Average Diluted Share | $35.1M | $34.5M | $32.3M | $31.1M | $29.7M | |
| EBITDA | $13.2M | $19.3M | $468K | -$7.6M | -$7.3M | |
| EBIT | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Revenue (Reported) | $458.7M | $551.5M | $465.3M | $402.9M | $370.3M | |
| Operating Income (Reported) | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Operating Income (Adjusted) | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.3B | $2.2B | $1.8B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.7B | $1.6B | $1.4B | $1.1B | |
| Gross Profit | $425.1M | $589.6M | $585.4M | $482.3M | $393.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $388.3M | $487.5M | $502.8M | $478.9M | $398.6M | |
| Other Inc / (Exp) | -- | -- | -- | -$9.5M | -$59.7M | |
| Operating Expenses | $418.2M | $515.4M | $531.2M | $506.3M | $425.1M | |
| Operating Income | $6.8M | $74.2M | $54.3M | -$23.9M | -$31.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.8M | $79.6M | $56M | -$29.6M | -$88.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6.8M | $14.3M | $8.5M | -$18M | $49.9M | |
| Net Income to Company | $15.6M | $65.3M | $47.5M | -$11.6M | -$138.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.6M | $65.3M | $47.5M | -$11.6M | -$138.4M | |
| Basic EPS (Cont. Ops) | $0.45 | $1.88 | $1.46 | -$0.37 | -$4.59 | |
| Diluted EPS (Cont. Ops) | $0.45 | $1.85 | $1.43 | -$0.37 | -$4.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $211.9M | $102.1M | $82.6M | $3.4M | -$3.3M | |
| EBIT | $182M | $74.2M | $54.3M | -$23.9M | -$31.7M | |
| Revenue (Reported) | $1.8B | $2.3B | $2.2B | $1.8B | $1.5B | |
| Operating Income (Reported) | $6.8M | $74.2M | $54.3M | -$23.9M | -$31.7M | |
| Operating Income (Adjusted) | $182M | $74.2M | $54.3M | -$23.9M | -$31.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $458.7M | $551.5M | $465.3M | $402.9M | $370.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $348.1M | $411.7M | $342.2M | $303.5M | $283.9M | |
| Gross Profit | $110.6M | $139.8M | $123.1M | $99.4M | $86.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $97.4M | $120.6M | $122.6M | $106.9M | $94.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $104.4M | $127.9M | $129.1M | $114.9M | $100.5M | |
| Operating Income | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.8M | $12.5M | -$4.9M | -$13.9M | -$13.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$112K | $2M | -$640K | -$12.2M | $418K | |
| Net Income to Company | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Basic EPS (Cont. Ops) | $0.20 | $0.31 | -$0.13 | -$0.05 | -$0.48 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.30 | -$0.13 | -$0.05 | -$0.48 | |
| Weighted Average Basic Share | $34.7M | $33.9M | $32.3M | $31.1M | $29.7M | |
| Weighted Average Diluted Share | $35.1M | $34.5M | $32.3M | $31.1M | $29.7M | |
| EBITDA | $13.2M | $19.3M | $468K | -$7.6M | -$7.3M | |
| EBIT | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Revenue (Reported) | $458.7M | $551.5M | $465.3M | $402.9M | $370.3M | |
| Operating Income (Reported) | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Operating Income (Adjusted) | $6.2M | $12M | -$5.9M | -$15.5M | -$14.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $62.5M | $49.9M | $72.1M | $61.9M | $22.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $278.3M | $353.9M | $314.3M | $252.5M | $214.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $17.3M | -- | $19.4M | $17.8M | $14.8M | |
| Other Current Assets | $8.9M | $31.6M | $13.1M | $6.3M | $5.2M | |
| Total Current Assets | $378.9M | $445.1M | $430.2M | $355M | $277.1M | |
| Property Plant And Equipment | $137.7M | $234.4M | $146.6M | $154.7M | $136.9M | |
| Long-Term Investments | $152.2M | $167.7M | $150.2M | $155.6M | $141.4M | |
| Goodwill | $94.9M | $94.5M | $93.8M | $84.1M | $24.5M | |
| Other Intangibles | $28.9M | -$68.9M | $16.2M | $10.5M | $5.9M | |
| Other Long-Term Assets | $72.8M | $69.7M | $81.4M | $50.2M | $50.4M | |
| Total Assets | $980.6M | $1B | $1B | $899.4M | $675.4M | |
| Accounts Payable | $58.4M | $77.2M | $76.6M | $56.4M | $45.6M | |
| Accrued Expenses | $122.7M | $100.2M | $92.2M | $80.1M | $61.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $13.9M | $12.1M | $12M | $11.9M | $11.1M | |
| Other Current Liabilities | $7.9M | $7.5M | $7.1M | $8.5M | $5.3M | |
| Total Current Liabilities | $269M | $258.5M | $242.9M | $204.1M | $160.1M | |
| Long-Term Debt | -- | -- | -- | -- | $7.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $543.4M | $540.2M | $523.1M | $441.5M | $360M | |
| Common Stock | $1K | $1K | $1K | $1K | $1K | |
| Other Common Equity Adj | -$14.8M | -$15.7M | -$20M | -$20.7M | -$22.2M | |
| Common Equity | $437.2M | $493.1M | $496.3M | $457.9M | $315.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $437.2M | $493.1M | $496.3M | $457.9M | $315.4M | |
| Total Liabilities and Equity | $980.6M | $1B | $1B | $899.4M | $675.4M | |
| Cash and Short Terms | $62.5M | $49.9M | $72.1M | $61.9M | $22.5M | |
| Total Debt | -- | -- | -- | -- | $7.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $88M | $36.7M | $47.2M | $36.2M | $23.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $260.1M | $325.2M | $282M | $244.2M | $219.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $18.7M | $19.3M | $20.7M | $19.4M | $15.5M | |
| Other Current Assets | $10.7M | $6.4M | $8.7M | $5.6M | $4M | |
| Total Current Assets | $384M | $398.3M | $371.3M | $315.4M | $281M | |
| Property Plant And Equipment | $136.2M | $143.5M | $148.8M | $154.9M | $133.9M | |
| Long-Term Investments | -- | $159.1M | $150.5M | $152.4M | $129.1M | |
| Goodwill | $94.9M | $94.7M | $93.8M | $83.9M | $42.3M | |
| Other Intangibles | $27.1M | $20.7M | $15M | $9M | $20.4M | |
| Other Long-Term Assets | $248.6M | $73.7M | $79.5M | $50.1M | $52.2M | |
| Total Assets | $979.4M | $980.9M | $957.1M | $868.6M | $692.5M | |
| Accounts Payable | $48.2M | $63.5M | $64M | $43.6M | $38M | |
| Accrued Expenses | $68.7M | $81.1M | $81.1M | $81M | $66.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $13.3M | $12.6M | $11.9M | $11.9M | $11M | |
| Other Current Liabilities | $8.1M | $9.7M | $6.9M | $6.1M | $5.5M | |
| Total Current Liabilities | $258.5M | $225.9M | $214.9M | $184M | $156.3M | |
| Long-Term Debt | -- | $4M | -- | -- | $57.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $533.8M | $513.4M | $489.5M | $422.2M | $390.3M | |
| Common Stock | $1K | $1K | $1K | $1K | $1K | |
| Other Common Equity Adj | -$14.3M | -$15.6M | -$20.3M | -$20.8M | -$22.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $445.6M | $467.6M | $467.6M | $446.4M | $302.2M | |
| Total Liabilities and Equity | $979.4M | $980.9M | $957.1M | $868.6M | $692.5M | |
| Cash and Short Terms | $88M | $36.7M | $47.2M | $36.2M | $23.1M | |
| Total Debt | -- | $4M | -- | -- | $57.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$141.8M | $61.6M | $62.3M | -$14.2M | -$125.7M | |
| Depreciation & Amoritzation | $32M | $27.6M | $29.3M | $25.8M | $29.6M | |
| Stock-Based Compensation | $9.1M | $13.9M | $9.7M | $13.9M | $7.6M | |
| Change in Accounts Receivable | $57.1M | -$81.6M | $34.8M | $56.8M | $35.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $152.5M | $20.4M | $120.5M | $34.8M | -$17.1M | |
| Capital Expenditures | $27.1M | $35M | $30.6M | $31.3M | $24.2M | |
| Cash Acquisitions | -- | -- | -- | -- | $3.1M | |
| Cash From Investing | -$34.4M | -$16.2M | -$20.9M | -$32.3M | -$2.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$54.8M | -$19.9M | -$65.4M | -$38.3M | -$23.6M | |
| Other Financing Activities | -$1.5M | -$345K | -$253K | -$100K | -$1.8M | |
| Cash From Financing | -$92.5M | -$19.1M | -$64.7M | -$37.6M | -$17.1M | |
| Beginning Cash (CF) | $92.4M | $118.6M | $103.2M | $135.6M | $99.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25.6M | -$14.9M | $34.9M | -$35.2M | -$36.6M | |
| Ending Cash (CF) | $118.6M | $103.2M | $135.6M | $99.3M | $61.1M | |
| Levered Free Cash Flow | $125.5M | -$14.6M | $89.9M | $3.5M | -$41.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Depreciation & Amoritzation | $7M | $7.3M | $6.4M | $8M | $6.8M | |
| Stock-Based Compensation | $3.3M | $3.8M | $2.6M | $2.1M | $2.1M | |
| Change in Accounts Receivable | $22.9M | $27.7M | $31M | $8.3M | $9.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $27.9M | $26.4M | $9.2M | -$14.2M | -$22.1M | |
| Capital Expenditures | $10M | $5.8M | $8.1M | $7.4M | $4.7M | |
| Cash Acquisitions | -- | -- | -- | $2.9M | -$30M | |
| Cash From Investing | -$3.2M | $255K | -$8.4M | $919K | -$24M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.6M | -$40.3M | -$27.1M | -$12.1M | -$895K | |
| Other Financing Activities | -$94K | -$72K | -$45K | -$1.8M | -$6K | |
| Cash From Financing | -$2.4M | -$36M | -$26.8M | -$13.7M | $49.4M | |
| Beginning Cash (CF) | $118.6M | $103.2M | $135.6M | $99.3M | $61.1M | |
| Foreign Exchange Rate Adjustment | $262K | -$57K | $9K | -$604K | -$230K | |
| Additions / Reductions | $22.3M | -$9.4M | -$26.1M | -$27M | $3.3M | |
| Ending Cash (CF) | $141.2M | $93.8M | $109.6M | $71.7M | $64.2M | |
| Levered Free Cash Flow | $17.9M | $20.7M | $1.1M | -$21.6M | -$26.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.6M | $65.3M | $47.5M | -$11.6M | -$138.4M | |
| Depreciation & Amoritzation | $29.9M | $27.9M | $28.4M | $27.4M | $28.4M | |
| Stock-Based Compensation | $10.9M | $14.4M | $8.5M | $13.4M | $7.5M | |
| Change in Accounts Receivable | $34.2M | -$76.8M | $38.1M | $34M | $36.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $152.8M | $19M | $103.2M | $11.4M | -$24.9M | |
| Capital Expenditures | $30M | $30.8M | $32.9M | $30.6M | $21.5M | |
| Cash Acquisitions | -- | -- | -- | $2.9M | -$29.9M | |
| Cash From Investing | -$36.9M | -$12.8M | -$29.6M | -$23M | -$27.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3.2M | -$57.7M | -$52.2M | -$23.3M | -$12.4M | |
| Other Financing Activities | -$1.1M | -$323K | -$226K | -$1.9M | -$10K | |
| Cash From Financing | -$297M | -$52.8M | -$55.5M | -$24.4M | $45.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$181M | -$46.6M | $18.2M | -$36.1M | -$6.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $122.8M | -$11.8M | $70.3M | -$19.2M | -$46.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.9M | $10.5M | -$4.3M | -$1.7M | -$14.3M | |
| Depreciation & Amoritzation | $7M | $7.3M | $6.4M | $8M | $6.8M | |
| Stock-Based Compensation | $3.3M | $3.8M | $2.6M | $2.1M | $2.1M | |
| Change in Accounts Receivable | $22.9M | $27.7M | $31M | $8.3M | $9.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $27.9M | $26.4M | $9.2M | -$14.2M | -$22.1M | |
| Capital Expenditures | $10M | $5.8M | $8.1M | $7.4M | $4.7M | |
| Cash Acquisitions | -- | -- | -- | $2.9M | -$30M | |
| Cash From Investing | -$3.2M | $255K | -$8.4M | $919K | -$24M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.6M | -$40.3M | -$27.1M | -$12.1M | -$895K | |
| Other Financing Activities | -$94K | -$72K | -$45K | -$1.8M | -$6K | |
| Cash From Financing | -$2.4M | -$36M | -$26.8M | -$13.7M | $49.4M | |
| Beginning Cash (CF) | $118.6M | $103.2M | $135.6M | $99.3M | $61.1M | |
| Foreign Exchange Rate Adjustment | $262K | -$57K | $9K | -$604K | -$230K | |
| Additions / Reductions | $22.3M | -$9.4M | -$26.1M | -$27M | $3.3M | |
| Ending Cash (CF) | $141.2M | $93.8M | $109.6M | $71.7M | $64.2M | |
| Levered Free Cash Flow | $17.9M | $20.7M | $1.1M | -$21.6M | -$26.8M | |
Get TBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TBI
Sector
P/E ratio
--
18.58x
PEG ratio
0.00x
0.25x
P/B ratio
0.64x
1.75x
Price / LTM sales
0.13x
0.94x
Growth Metrics
TBI
Sector
Revenue growth
-8.09%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
-7.93%
4.35%
Earnings forecast
-$0.10
$0.40
Profitability
TBI
Sector
Profitability FY 2024
$406.4M
$393.9M
Return on invested capital
-38.57%
5.32%
Return on assets
-18.89%
3.49%
Return on equity
-40.03%
8.55%
Earnings Date
Last Earnings Date
May
5
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Aug
4
Balance Sheet
TBI
Sector
Total cash
$23.1M
$154.3M
Short term investments
--
$35.5M
Total assets
$675.4M
$1.7B
Long term debt
$57.8M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
